Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(27 sites)
United States
Mayo Clinic Hospital in Arizona, Phoenix, Arizona UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine, California Los Angeles General Medical Center, Los Angeles, California USC / Norris Comprehensive Cancer Center, Los Angeles, California UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California